浙江省肿瘤防治联盟成立 美尊医询升级中美医疗沟通效率

Submitted by admin on Tue, 11/01/2016 - 13:07


2016年10月15-16日，由中国肿瘤防治联盟浙江省联盟筹委会与浙江省肿瘤靶向治疗技术指导中心筹委会共同主办，美中抗癌协会（USCACA）协办的中国肿瘤防治联盟浙江省联盟暨浙江省肿瘤靶向治疗技术指导中心成立大会，在浙江杭州邵逸夫医院下沙院区圆满召开。近200位顶级肿瘤专科专家参会。作为专注于管理中美肿瘤治疗资源的移动智慧医疗服务平台，美尊医询全程助力大会召开，连接美方高端专家资源，提升中美医学交流水平！


行业聚焦：打造中美肿瘤医疗连接平台的呼声


Partnership for 5 more years

Submitted by admin on Mon, 09/19/2016 - 10:41
Dr. George Wilding, a Board Member of USCACA and the Vice Provost of MD Anderson Cancer Center, led a delegation to attend the 2nd International Conference on Translational Cancer Research held in Tianjin during August 2016. Dr. Wilding and Dr. Ping Wang, the President of Tianjin Medical University Cancer Hospital and Institute, also signed an Agreement to continue the Sister Institute Relationship for 5 additional years after 10 years’ highly successful partnership.


VIP keynote Speaker Invitation

Submitted by admin on Sun, 09/18/2016 - 17:34


USCACA is an endorser of the World Precision Medicine Summit 2016 to be held in Shanghai during December 3-4. Dr.Wei Zhang will serve as a moderator and panel discussant.USCACA friend, the Director of Wake Forest Cancer Center, Dr. Boris Pasche will deliver a keynote speech on precision oncology initiative at Wake Forest.


Prof. Jilong Yang, the first USCACA – NFCR Scholar (2010) is to speak at AACR conference

Submitted by admin on Sun, 09/18/2016 - 13:50


Prof. Jilong Yang, the first US Chinese Anti‐Cancer Association (USCACA) – National Foundation for Cancer Research (NFCR) Scholar (2010) is to speak at AACR conference “New Horizons in Cancer Research”, Nov 2-5, Shanghai, China. Please also see Yang’s new book – “The Knowledge of Sarcoma – 认识肉瘤”


Pages